Cédric Le May - Concepedia

Author

Cédric Le May

Inserm ORCID

Also Known As

C Lemay, C May, C. Le May, C. May, CEDRIC LE MAY, Cedric Le May, Cedric LeMay, Cedric Lemay, Cedric May, Cédric Le May

175

Publications

5.1K

Citations

H-Index

Concepts

All Affiliations

Inserm Institut du Thorax Centre National de la Recherche Scientifique Nantes Université Centre Hospitalier Universitaire de Nantes

About

Cédric Le May is an author at Inserm specializing in medicine, metabolic syndrome, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	26	1.1K
2	Health Sciences	10	10	360
3	Public Health	3	3	176
4	Natural Sciences	2	2	48
5	Social Sciences	1	1	27

Cédric Le May

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Estrogens protect pancreatic β-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice Cédric Le May, Khoi Chu, Min Hu, Proceedings of the National Academy of Sciences	2006	484
Importance of Extranuclear Estrogen Receptor-α and Membrane G Protein–Coupled Estrogen Receptor in Pancreatic Islet Survival Suhuan Liu, Cédric Le May, Winifred P.S. Wong, Diabetes	2009	194
Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents β cell failure in rodent models of type 2 diabetes Joseph P. Tiano, Viviane Delghingaro‐Augusto, Cédric Le May, Journal of Clinical Investigation	2011	177
Transintestinal Cholesterol Excretion Is an Active Metabolic Process Modulated by PCSK9 and Statin Involving ABCB1 Cédric Le May, J Berger, Anne Lespine, Arteriosclerosis Thrombosis and Vascular Biology	2013	169
Proprotein Convertase Subtilisin Kexin Type 9 Null Mice Are Protected From Postprandial Triglyceridemia Cédric Le May, Sanae Kourimate, Cédric Langhi, Arteriosclerosis Thrombosis and Vascular Biology	2009	161
The Sodium–Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model Michaël Joubert, Benoît Jagu, David Montaigne, Diabetes	2017	149
Extranuclear estrogen receptor-α stimulates NeuroD1 binding to the insulin promoter and favors insulin synthesis Winifred P.S. Wong, Joseph P. Tiano, Suhuan Liu, Proceedings of the National Academy of Sciences	2010	136
PCSK9 Dominant Negative Mutant Results in Increased LDL Catabolic Rate and Familial Hypobetalipoproteinemia Bertrand Cariou, Khadija Ouguerram, Yassine Zaïr, Arteriosclerosis Thrombosis and Vascular Biology	2009	136
PAX4 gene variations predispose to ketosis-prone diabetes Franck Mauvais-Jarvis, Stuart B. Smith, Cédric Le May, Human Molecular Genetics	2004	124
Plasma PCSK9 concentrations during an oral fat load and after short term high-fat, high-fat high-protein and high-fructose diets Bertrand Cariou, Cédric Langhi, M. Le Bras, Nutrition & Metabolism	2013	110

Page 1